These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16397944)

  • 1. Ritonavir and lopinavir/ritonavir package inserts are updated.
    AIDS Alert; 2005 Dec; 20(12):143-4. PubMed ID: 16397944
    [No Abstract]   [Full Text] [Related]  

  • 2. Lopinavir/ritonavir. (Kaletra).
    Res Initiat Treat Action; 2000 Dec; 6(4):16-8. PubMed ID: 11708169
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HIV agents. Using only lopinavir/ritonavir (Kaletra).
    TreatmentUpdate; 2008 Jan; 20(1):1-2. PubMed ID: 18320690
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar; 20(2):5-6. PubMed ID: 18661644
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
    AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
    [No Abstract]   [Full Text] [Related]  

  • 6. Lopinavir + ritonavir tablets: new formulation. More convenient, but minimal evaluation.
    Prescrire Int; 2007 Aug; 16(90):148. PubMed ID: 17724839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. HIV-1 adult treatment guidelines are updated.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug interactions. Coming soon--a new formulation of Kaletra.
    TreatmentUpdate; 2006; 18(3):7. PubMed ID: 17209241
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children.
    Larrú B; Resino S; Bellón JM; de José MI; Fortuny C; Navarro ML; Gurbindo MD; Ramos JT; Soler Palacín P; Léon JA; Asensi M; Mellado MJ; Muñoz-Fernández MA
    J Antimicrob Chemother; 2008 Jan; 61(1):183-90. PubMed ID: 18025025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions. Kaletra and ezetimibe.
    TreatmentUpdate; 2006; 18(3):8. PubMed ID: 17209242
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-HIV agents. Monotherapy studies--points to consider.
    TreatmentUpdate; 2008 Jan; 20(1):3-4. PubMed ID: 18320692
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interactions. Kaletra and atazanavir.
    TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lopinavir/ritonavir monotherapy in the treatment of HIV infection. Introduction].
    Pulido Ortega F; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 16():1. PubMed ID: 19572436
    [No Abstract]   [Full Text] [Related]  

  • 14. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.
    Pulido F; Arribas JR; Delgado R; Cabrero E; González-García J; Pérez-Elias MJ; Arranz A; Portilla J; Pasquau J; Iribarren JA; Rubio R; Norton M;
    AIDS; 2008 Jan; 22(2):F1-9. PubMed ID: 18097218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CASTLE study showed similar efficacy.
    AIDS Patient Care STDS; 2008 Mar; 22(3):253. PubMed ID: 18348342
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency.
    Resino S; Bellón JM; Muñoz-Fernández MA;
    J Antimicrob Chemother; 2006 Mar; 57(3):579-82. PubMed ID: 16446377
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with the combined use of lopinavir/ritonavir and rifampicin.
    L'homme RF; Nijland HM; Gras L; Aarnoutse RE; van Crevel R; Boeree M; Brinkman K; Prins JM; Juttmann JR; Burger DM
    AIDS; 2009 Apr; 23(7):863-5. PubMed ID: 19352137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis coinfection and LPV/RTV.
    Carter M
    IAPAC Mon; 2004 Oct; 10(10):398. PubMed ID: 15801120
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. A trial of Kaletra monotherapy.
    TreatmentUpdate; 2008 Jan; 20(1):2-3. PubMed ID: 18320691
    [No Abstract]   [Full Text] [Related]  

  • 20. Civil society strategy for the compulsory licensing of lopinavir/ritonavir: the Brazilian case.
    Vieira MF; Reis R; Chaves G
    HIV AIDS Policy Law Rev; 2008 Dec; 13(2-3):80-1. PubMed ID: 19297771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.